000018858 000__ 01134cas\a2200277\a\4500
000018858 001__ 18858
000018858 005__ 20220217103302.0
000018858 008__ 771208c19uu9999mduuu\\\\\\\\f0\\\a0eng\d
000018858 035__ $$a(OCoLC)ocm03472908
000018858 035__ $$a18858
000018858 037__ $$bOffice of Recombinant DNA Activities, National Institutes of Health, Bethesda, Md., 20205
000018858 040__ $$aDRB$$cDRB$$dMUL$$dGPO$$dRCS
000018858 043__ $$an-us---
000018858 049__ $$aISEA
000018858 074__ $$a507-H
000018858 0860_ $$aHE 20.3008:D 44/
000018858 090__ $$aQP624$$b.U54
000018858 1102_ $$aNational Institutes of Health (U.S.)
000018858 24510 $$aGuidelines for research involving recombinant DNA molecules /$$cNational Institutes of Health.
000018858 260__ $$a[Bethesda, Md.?] :$$bThe Institutes,
000018858 300__ $$av. ;$$c26 cm.
000018858 3621_ $$aBegan with 1976.
000018858 500__ $$aTitle from cover.
000018858 500__ $$aDescription based on: Nov. 1980.
000018858 650_0 $$aRecombinant DNA$$xResearch$$xLaw and legislation$$zUnited States$$vPeriodicals.
000018858 7700_ $$aNational Institute of Allergy and Infectious Diseases (U.S.).  Office of Recombinant DNA Activities.$$tAdministrative practices supplement to the NIH guidelines for research involving recombinant DNA molecules
000018858 85231 $$bdfich$$hHE 20.3008:$$iD 44/
000018858 86631 $$a996
000018858 909CO $$ooai:library.usi.edu:18858$$pGLOBAL_SET
000018858 980__ $$aBIB
000018858 980__ $$aGOV RESOURCE